DK1210441T3 - Varianter af gamma-kæden af AMPK, DNA-sekvenser der koder for disse, og anvendelser deraf - Google Patents

Varianter af gamma-kæden af AMPK, DNA-sekvenser der koder for disse, og anvendelser deraf

Info

Publication number
DK1210441T3
DK1210441T3 DK00967845T DK00967845T DK1210441T3 DK 1210441 T3 DK1210441 T3 DK 1210441T3 DK 00967845 T DK00967845 T DK 00967845T DK 00967845 T DK00967845 T DK 00967845T DK 1210441 T3 DK1210441 T3 DK 1210441T3
Authority
DK
Denmark
Prior art keywords
variants
ampk
sequences encoding
gamma chain
dna sequences
Prior art date
Application number
DK00967845T
Other languages
Danish (da)
English (en)
Inventor
Leif Andersson
Denis Milan
Joel Gellin
Christian Looft
Ernst Kalm
Annie Robic
Claire Rogel-Gaillard
Nathalie Iannuccelli
Roy Pascale Le
Patrick Chardon
Original Assignee
Arexis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arexis Ab filed Critical Arexis Ab
Application granted granted Critical
Publication of DK1210441T3 publication Critical patent/DK1210441T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00967845T 1999-09-10 2000-09-11 Varianter af gamma-kæden af AMPK, DNA-sekvenser der koder for disse, og anvendelser deraf DK1210441T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99402236 1999-09-10
EP00401388 2000-05-18
PCT/EP2000/009896 WO2001020003A2 (en) 1999-09-10 2000-09-11 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof

Publications (1)

Publication Number Publication Date
DK1210441T3 true DK1210441T3 (da) 2005-07-04

Family

ID=26073491

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00967845T DK1210441T3 (da) 1999-09-10 2000-09-11 Varianter af gamma-kæden af AMPK, DNA-sekvenser der koder for disse, og anvendelser deraf

Country Status (15)

Country Link
US (1) US7462693B2 (ja)
EP (1) EP1210441B1 (ja)
JP (2) JP3983051B2 (ja)
KR (1) KR100806954B1 (ja)
CN (1) CN100439503C (ja)
AT (1) ATE293167T1 (ja)
AU (1) AU781744B2 (ja)
BR (1) BR0013890A (ja)
CA (1) CA2384313C (ja)
DE (2) DE00967845T1 (ja)
DK (1) DK1210441T3 (ja)
ES (1) ES2239618T3 (ja)
MX (1) MXPA02002613A (ja)
PL (1) PL354753A1 (ja)
WO (1) WO2001020003A2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142310A1 (en) * 2000-04-07 2002-10-03 Leif Andersson Variants of the human AMP-activated protein kinase gamma 3 subunit
EP1354061A2 (en) 2000-09-08 2003-10-22 Iowa State University Research Foundation, Inc. Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
US20060053499A1 (en) 2002-01-18 2006-03-09 Doris Kretzschmar An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
AU2003207884B2 (en) 2002-02-01 2008-07-31 Arexis Ab Variants of the alpha 1 subunit of human AMPK
WO2003064465A2 (en) * 2002-02-01 2003-08-07 Arexis Ab Prkag3 gene promoter and uses thereof
DE60331416D1 (de) * 2002-02-01 2010-04-08 Arexis Ab Transgene mäuse, die prkag3 exprimieren
GB0221148D0 (en) * 2002-09-12 2002-10-23 Univ Dundee Kinase inhibitor screening assay
US8688385B2 (en) * 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
CN104894239B (zh) * 2015-05-11 2017-12-19 中国农业科学院植物保护研究所 一种用AMPKγ基因评价昆虫发育速率的方法
CN113207808B (zh) * 2021-06-03 2023-09-29 贵州大学 一种柯乐猪的选育方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041156A (en) * 1974-11-08 1977-08-09 Mitsubishi Chemical Industries Limited N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4018915A (en) * 1976-01-05 1977-04-19 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4055651A (en) * 1974-11-08 1977-10-25 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4070457A (en) * 1974-11-08 1978-01-24 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4104392A (en) * 1974-11-08 1978-08-01 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, and antithrombotic compositions and methods employing them
US4055636A (en) * 1974-11-08 1977-10-25 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4046876A (en) * 1974-11-08 1977-09-06 Mitsubishi Chemical Industries Limited N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4073914A (en) * 1974-11-08 1978-02-14 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4096255A (en) * 1974-11-08 1978-06-20 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides, and pharmaceutical salts, compositions and methods
US4036955A (en) * 1976-07-22 1977-07-19 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4018913A (en) * 1976-01-14 1977-04-19 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
AUPN745096A0 (en) * 1996-01-08 1996-02-01 St. Vincent's Institute Of Medical Research Novel amp activated protein kinase
US5885803A (en) * 1997-06-19 1999-03-23 Incyte Pharmaceuticals, Inc. Disease associated protein kinases
US20020142310A1 (en) 2000-04-07 2002-10-03 Leif Andersson Variants of the human AMP-activated protein kinase gamma 3 subunit
EP1354061A2 (en) 2000-09-08 2003-10-22 Iowa State University Research Foundation, Inc. Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
WO2003064465A2 (en) 2002-02-01 2003-08-07 Arexis Ab Prkag3 gene promoter and uses thereof
AU2003207884B2 (en) 2002-02-01 2008-07-31 Arexis Ab Variants of the alpha 1 subunit of human AMPK
DE60331416D1 (de) 2002-02-01 2010-04-08 Arexis Ab Transgene mäuse, die prkag3 exprimieren

Also Published As

Publication number Publication date
DE60019433T2 (de) 2006-02-23
ES2239618T3 (es) 2005-10-01
AU7786400A (en) 2001-04-17
DE00967845T1 (de) 2004-07-08
CN100439503C (zh) 2008-12-03
KR20020062918A (ko) 2002-07-31
DE60019433D1 (de) 2005-05-19
AU781744B2 (en) 2005-06-09
WO2001020003A3 (en) 2001-05-17
CA2384313A1 (en) 2001-03-22
MXPA02002613A (es) 2003-10-14
EP1210441A2 (en) 2002-06-05
JP2003509052A (ja) 2003-03-11
ATE293167T1 (de) 2005-04-15
CA2384313C (en) 2010-10-19
US20070199081A1 (en) 2007-08-23
PL354753A1 (en) 2004-02-23
WO2001020003A2 (en) 2001-03-22
US7462693B2 (en) 2008-12-09
BR0013890A (pt) 2002-05-07
JP2007190021A (ja) 2007-08-02
CN1402787A (zh) 2003-03-12
KR100806954B1 (ko) 2008-02-22
JP3983051B2 (ja) 2007-09-26
EP1210441B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
NO20053600D0 (no) Pyrazolo (3,4-b)pyridinforbindelser og anvendelse derav som fosfodiesterase inhibitorer.
ATE256131T1 (de) Calanolide zur hemmung von btk
LTC1663240I2 (lt) Pirimidino deriniai, turintys nnrti su rt slopikliais
DK2333099T3 (da) Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf
DK1412357T3 (da) Beta-aminotetrahydroimidazo-(1,2-a)-pyraziner og tetrahydrotriazolo-(4,3-a)-pyraziner som dipeptidylpeptidaseinhibitorer til behandling eller forebyggelse af diabetes
BRPI0515012A (pt) substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
DK1641910T3 (da) Glucanaser, nucleinsyrer, som koder for disse, og fremgangsmåder til at fremstille og benytte disse
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
DE60236367D1 (de) Echolöscher, der eine weitere reduktion des restechos sicherstellt
DK1450847T3 (da) Apo2-ligand/TRAIL-formuleringer og anvendelser deraf
DK1210441T3 (da) Varianter af gamma-kæden af AMPK, DNA-sekvenser der koder for disse, og anvendelser deraf
UY28731A1 (es) Compuestos quimicos
WO2007120333A3 (en) Tetracyclic kinase inhibitors
AU2003256587A8 (en) Detection of chemical ligation using fluorescence quenching leaving groups
NO20013853L (no) Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer
DE60317103D1 (de) Feuchtigkeitshärtbare, von isocyanatgruppen freie acrylbeschichtungen
DK1465927T3 (da) BAG3-antistoffer til anvendelse til forskning, diagnostik og behandling af sygdomme, der omfatter celledød
ITMI20030897A1 (it) Procedimento e apparecchiatura per frazionare sangue.
DK1562985T3 (da) "Anvendelse af opløselige former af CD83 og nukleinsyrer, der koder for disse, til behandling eller forebyggelse af sygdomme"
DE50309381D1 (de) Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen
ITSV20030016A1 (it) Sostanze contenenti tannini o miscele di tannini.
DK2845594T3 (da) Anvendelse af dihydroimidazoloner til behandlingen af hunde.
DZ3174A1 (fr) Composition catalytique et procédé utilisant cettecomposition.